Two randomised controlled trials, EMGT and UKGTS, have examined the factors affecting the risk of glaucoma progression. Global target IOPs are not the best option for all patients.
Dr Sara Giammaria
Advertisement
Articles by Dr Sara Giammaria
Advertisement
Latest Updated Articles
Using pivotal study data to guide glaucoma patient management decisionsPublished: June 9th 2021 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: New horizons in research and risk management for ROP
2
FLORetina 2025: EU-ROP Registry bridges borders for real-world insight
3
FLORetina 2025: Enrico Borrelli on reframing retinal disease through the lens of choroidal health
4
FLORetina 2025: Antithrombotic use examined in wet AMD submacular hemorrhage
5
